l -Deprenyl metabolism by the cytochrome P450 system in monkey (Cercopithecus aethiops) liver microsomes

References

• AMATO, G., LONGO V., MAZZACARO, A. and GERVASI, P. G., 1998, Chlorzoxazone 6-hydroxylase and p-nitrophenol hydroxylase as the most suitable activities for assaying cytochrome P450 2E1 in cynomolgus monkey liver. Drug Metabolism and Disposition, 26, 483–489.
   Google Scholar
• BACH, M. V., COUTTS, R. T. and BAKER, G. B., 2000, Metabolism of N,N-dialkylated amphetamines, including deprenyl, by CYP2D6 expressed in a human cell line. Xenobiotica, 30, 297–306.
   PubMed Web of Science ®Google Scholar
• BAKER, G. B., URICHUK, L. J., MCKENNA, K. F. and KENNEDY, S. H., 1999, Metabolism of monoamine oxidase inhibitors. Cellular and Molecular Neurobiology, 19, 411–426.
   PubMed Web of Science ®Google Scholar
• BIRKMAYER, W., KNOLL, J., RIEDERER, P., YOUDIM, M. D. H., HARS, V. and MARTON, J., 1985, Increased life expectancy resulting from addition of /-deprenyl to Madopar treatment in Parkinson's disease: a long-term study. Journal of Neural Transmission, 64, 113–127.
   Google Scholar
• BULLOCK, P., PEARCE, R., DRAPER, A., PODVAL, J., BRACKEN, W., VELTMAN, J., THOMAS, P. and PARKINSON, A., 1995, Induction of liver microsomal cytochrome P450 in cynomolgus monkeys. Drug Metabolism and Disposition, 23, 736–748.
   PubMed Web of Science ®Google Scholar
• DUCHARME, J., ABDULLAH, S. and WAINER, I. W., 1996, Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity. Journal of Chromatography Biomedical Application, 678, 113–128.
   Google Scholar
• GERLACH, M., YOUDIM, M. B. and RIEDERER, P., 1996, Pharmacology of selegiline. Neurology, 47 (Suppl. 3), S137–145.
   PubMed Web of Science ®Google Scholar
• GRACE, J. M., KINTER, M. T. and MACDONALD, T. L., 1994, Atypical metabolism of deprenyl and its enantiomer (S)-( + )-N,alpha-dimethyl-N-propynylphenethylamine, by cytochrome P450 2D6. Chemical Research in Toxicology, 7, 286–290.
   PubMed Web of Science ®Google Scholar
• GUENGERICH F. P., GILLAM E. M. and SHIMADA T., 1996, New applications of bacterial systems to problems in toxicology. Critical Review in Toxicology, 26, 551–83.
   PubMed Web of Science ®Google Scholar
• HIDESTRAND, M., OSCARSON, M., SALONEN, J. S., NYMAN, L., PELKONEN, O., TURPEINEN, M. and INGELMAN-SUNDBERG, M., 2001, CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes. Drug Metabolism and Disposition, 29, 1480–1484.
   Google Scholar
• JAN, C., FRANCOIS, C., TANDE, D., YELNIK, J., TREMBLAY, L., AGID, Y. and HIRSCH, E., 2000, Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients. European Journal of Neuroscience, 12, 4525–4535.
   PubMed Web of Science ®Google Scholar
• Ko, I. Y., PARK, S. S., SONG, B. J., PATTEN, C., TAN, Y. Z., HAH, Y. C., YANG, C. S. and GELBOIN, H. V., 1987, Monoclonal antibodies to ethanol-induced rat liver cytochrome P-450 that metabolizes aniline and nitrosamines. Cancer Research, 47, 3101–3109.
   PubMed Web of Science ®Google Scholar
• KOENIGS, L. L., PETER, R. M., THOMPSON, S. J., RETTIE, A. E. and TRAGER, W. F., 1997, Mechanism-based inactivation of human liver cytochrome P4502A6 by 8-methoxypsoralen. Drug Metabolism and Disposition, 25, 1407–1415.
   PubMed Web of Science ®Google Scholar
• KRIJGSHELD, K. R. and GRAM, T. E., 1984, Selective induction of renal microsomal cytochrome P450-linked monooxygenases by 1,1-dichloroethylene in mice. Biochemical Pharmacology, 33, 1951–1956.
   PubMed Web of Science ®Google Scholar
• LAEMMLI, U. K., 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685.
   PubMed Web of Science ®Google Scholar
• Li, Y., Li, N.-Y. and SELLERS, E. M., 1997, Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes. European Journal of Drug Metabolism and Pharmacokinetics, 22, 295–304.
   Google Scholar
• LONGO, V., MAZZACARO, A., VENTURA, P. and GERVASI, P. G., 1992, Drug-metabolizing enzymes in respiratory nasal mucosa and liver of cynomolgus monkey. Xenobiotica, 22, 427–431.
   PubMed Web of Science ®Google Scholar
• LOWRY, O., ROSENBROUGH, N., FARR, A. and RANDALL, R., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• MAENPAA, J., SIGUSCH, H., RAUNIO, H., SYNGELMA, T., VUORELA, P., VUORELA, H. and PELKONEN, O. 1993, Differential inhibition of coumarin-7-hydroxylase activity in mouse and human liver microsomes. Biochemical Pharmacology, 45, 1035–1042.
   PubMed Web of Science ®Google Scholar
• MASTERS, B. S. S., WILLIAM, C. H. and KAMIN, H., 1967, The preparation and properties of microsomal NADPH-cytochrome c reductase from pig liver. In R. W. Estabrook and E. E. Pulman (eds), Methods in Enzymology, vol. 10 (New York: Academy Press), pp. 565–573.
   Google Scholar
• OHMORI, S., HORIE, T., GUENGERICH, F. P., KIUCHI, M. and KITADA, M., 1993, Purification and characterization of two forms of hepatic microsomal cytochrome P450 from untreated cynomolgus monkeys. Archives of Biochemistry and Biophysics, 305, 405–413.
   PubMed Web of Science ®Google Scholar
• OHTA, K., KITADA, M., HASHIZUME, T., KOMORI M., OHI, H. and KAMATAKI, T., 1989, Purification of cytochrome P450 from polychlorinated biphenyl-treated crab-eating monkeys: high homology to a form of human cytochrome P450. Biochimica et Biophysica Acta, 996, 142–145.
   Google Scholar
• OLANOW, C. W. and TATTON, W. G., 1999, Ethiology and pathogenesis of Parkinson's disease. Annual Review of Neuroscience, 22, 123–144.
   PubMed Web of Science ®Google Scholar
• OMURA, T. and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370–2378.
   PubMed Web of Science ®Google Scholar
• OTTON, S. V., TYNDALE, R. F., Wu, D., INABA T., KALOW W. and SELLERS, E. M., 1992, Catalytic and immunologic similarities between monkey and human liver cytochrome P450dbl (human cytochrome P450 2D6). Drug Metabolism and Disposition, 20, 1–5.
   Google Scholar
• PARKINSON, A., 1996, Biotransformation of xenobiotics. In C. D. Klaassen (ed.), Casarett Cs' Doull's Toxicology: The Basic Science of Poisons, 5th edn (New York: McGraw-Hill), pp. 113–186.
   Google Scholar
• REINKE, L. A. and MOYER, M. J., 1985, p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. Drug Metabolism and Disposition, 13, 548–552.
   PubMed Web of Science ®Google Scholar
• SAI, Y., DAI, R., YANG, T. Y. J., KRAUSZ, K. W., GONZALES, F. J., GELBOIN, H. V. and SHOU, M., 2000, Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450. Xenobiotica, 30, 327–343.
   Google Scholar
• SCHEININ, H., ANTTILA, M., DAHL, M. L., KARNANI, H., NYMAN, L., TAAVITSAINEN, P., PELKONEN, O. and BERTILSSON, L., 1998, CYP2D6 polymorphism is not crucial for the disposition of selegiline. Clinical Pharmacology and Therapeutics, 64, 402–411.
   PubMed Web of Science ®Google Scholar
• SHARER, J. E., SHIPLEY, L. A., VANDENBRANDEN, M. R., BINKLEY, N. S. and WRIGHTON, S. A., 1995, Comparison of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cymomolgus monkey. Drug Metabolism and Disposition, 23, 1231–1241.
   PubMed Web of Science ®Google Scholar
• SOUHAILI-EL AMRI, H., BATT, A. M. and SIEST, G., 1986, Comparison of cytochrome P450 content and activities in liver microsomes of seven animal species, including man. Xenobiotica, 16, 351–358.
   Google Scholar
• STEVENS, J. C., SHIPLEY, L. A., CASHMAN, J. R., VANDENBRANDEN, M. and WRIGHTON, A. S., 1993, Comparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities. Drug Metabolism and Disposition, 21, 753–760.
   PubMed Web of Science ®Google Scholar
• SZIRAKI, I., KARDOS, V., PATTHY, M., PATFALUSI, M., GL, J., SOLTI, M., KOLLAR, E. and SINGER, J., 1994, Amphetamine-metabolites of deprenyl involved in protection against neurotoxicity induced by MPTP and 2-methyl-MPTP. Journal of Neural Transmission, 41, 207–219.
   Google Scholar
• TAAVITSAINEN, P., ANTTILA, M., NYMAN, L., KARNANI, H., SALONEN, J. S. and PELKONEN, O., 2000, Selegiline metabolism and cytochrome P450 enzymes: in vitro study in human liver microsomes. Pharmacology and Toxicology, 86, 215–221.
   PubMedGoogle Scholar
• TATTON, W. G. and GREENWOOD, C. E., 1991, Rescue of dying neurons: a new action for /-deprenyl in MPTP parkinsonism. Journal of Neuroscience Research, 30, 666–672.
   PubMed Web of Science ®Google Scholar
• TAYLOR, J. R., ELSWORTH, J. D., ROTH, R. H., SLADEK, J. R., JR and REDMOND, D. E., JR, 1997, Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus). Neuroscience, 81, 745–755.
   PubMed Web of Science ®Google Scholar
• THE PARKINSON STUDY GROUP, 1993, Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. New England Journal of Medicine, 328, 176–183.
   PubMed Web of Science ®Google Scholar
• TIPTON, K. F., 1994, What is it that /-deprenyl (selegiline) might do? Clinical Pharmacology and Therapeutics, 56, 781–796.
   Google Scholar
• TOWBIN, H. T., STAEHELIN, T. and GORDON, J., 1992, Electrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology, 24, 145–149.
   PubMedGoogle Scholar
• Tu, Y. Y. and YANG, C. S., 1983, High-affinity nitrosamine dealkylase system in rat liver microsomes and its induction by fasting. Cancer Research, 43, 623–629.
   PubMed Web of Science ®Google Scholar
• VALOTI, M., FUSI, F., FROSINI, M., PESSINA, F., TIPTON, K. F. and SGARAGLI, G. P., 2000, Cytochrome P450-dependent N-dealkylation of /-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, cc-naphtofiavone and /-deprenyl. European Journal of Pharmacology, 391, 199–206.
   PubMed Web of Science ®Google Scholar
• WEAVER, R. J., DICKINS, M. and BURKE, M. D., 1999, A comparison of basal and induced hepatic microsomal cytochrome P450 monooxygenase activities in the cynomolgus monkey (Macaca fascicularis) and man. Xenobiotica, 29, 467–482.
   PubMed Web of Science ®Google Scholar
• WEAVER, R. J., THOMPSON, S., SMITH, G., DICKINS, M., ELCOMBE, C. R., MAYERS, R. T. and BURKE, M. D., 1994, A comparative study of constitutive and induced alkoxyresorufin O.dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes. Biochemical Pharmacology, 47, 763–773.
   PubMed Web of Science ®Google Scholar